167 related articles for article (PubMed ID: 38493517)
1. Predictive value of peripheral blood leukocytes-based methylation of Long non-coding RNA MALAT1 and H19 in the chemotherapy effect and prognosis of gastric cancer.
Wang F; Hu D; Lou X; Wang L; Wang Y; Zhang T; Yan Z; Meng N; Lei Y; Zou Y
Transl Oncol; 2024 Jun; 44():101929. PubMed ID: 38493517
[TBL] [Abstract][Full Text] [Related]
2. Peripheral Blood-Based DNA Methylation of Long Non-Coding RNA H19 and Metastasis-Associated Lung Adenocarcinoma Transcript 1 Promoters are Potential Non-Invasive Biomarkers for Gastric Cancer Detection.
Hu D; Lou X; Meng N; Li Z; Teng Y; Zou Y; Wang F
Cancer Control; 2021; 28():10732748211043667. PubMed ID: 34615385
[TBL] [Abstract][Full Text] [Related]
3. BNIP3 and DAPK1 methylation in peripheral blood leucocytes are noninvasive biomarkers for gastric cancer.
Wang F; Hu D; Lou X; Wang Y; Wang L; Zhang T; Yan Z; Meng N; Zou Y
Gene; 2024 Mar; 898():148109. PubMed ID: 38142898
[TBL] [Abstract][Full Text] [Related]
4. A meta-analysis of the clinicopathological significance of the lncRNA MALAT1 in human gastric cancer.
Bai S; Guo J; Zhang H
Front Oncol; 2023; 13():1257120. PubMed ID: 38239645
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of long non-coding RNA
Liao X; Chen J; Luo D; Luo B; Huang W; Xie W
Pathol Oncol Res; 2022; 28():1610808. PubMed ID: 36685103
[No Abstract] [Full Text] [Related]
6. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
[TBL] [Abstract][Full Text] [Related]
7. Circulating exosomal long non-coding RNA H19 as a potential novel diagnostic and prognostic biomarker for gastric cancer.
Zhou H; Shen W; Zou H; Lv Q; Shao P
J Int Med Res; 2020 Jul; 48(7):300060520934297. PubMed ID: 32660285
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression.
Zhang Y; Chen Z; Li MJ; Guo HY; Jing NC
Biomed Pharmacother; 2017 Jan; 85():264-271. PubMed ID: 27887846
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of long noncoding RNAs in gastric cancer: a meta-analysis.
Gao S; Zhao ZY; Wu R; Zhang Y; Zhang ZY
Onco Targets Ther; 2018; 11():4877-4891. PubMed ID: 30147339
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Role of Circulating Long Non-Coding RNA H19 as a Promising Novel Biomarker in Plasma of Patients with Gastric Cancer.
Hashad D; Elbanna A; Ibrahim A; Khedr G
J Clin Lab Anal; 2016 Nov; 30(6):1100-1105. PubMed ID: 27184562
[TBL] [Abstract][Full Text] [Related]
11. The Human RNA Surveillance Factor UPF1 Modulates Gastric Cancer Progression by Targeting Long Non-Coding RNA MALAT1.
Li L; Geng Y; Feng R; Zhu Q; Miao B; Cao J; Fei S
Cell Physiol Biochem; 2017; 42(6):2194-2206. PubMed ID: 28942451
[TBL] [Abstract][Full Text] [Related]
12. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
13. Pathways and role of MALAT1 in esophageal and gastric cancer.
Syllaios A; Moris D; Karachaliou GS; Sakellariou S; Karavokyros I; Gazouli M; Schizas D
Oncol Lett; 2021 May; 21(5):343. PubMed ID: 33747200
[TBL] [Abstract][Full Text] [Related]
14. Association of well-characterized lung cancer lncRNA polymorphisms with lung cancer susceptibility and platinum-based chemotherapy response.
Gong WJ; Yin JY; Li XP; Fang C; Xiao D; Zhang W; Zhou HH; Li X; Liu ZQ
Tumour Biol; 2016 Jun; 37(6):8349-58. PubMed ID: 26729200
[TBL] [Abstract][Full Text] [Related]
15. The lncRNA MALAT1 is a novel biomarker for gastric cancer metastasis.
Xia H; Chen Q; Chen Y; Ge X; Leng W; Tang Q; Ren M; Chen L; Yuan D; Zhang Y; Liu M; Gong Q; Bi F
Oncotarget; 2016 Aug; 7(35):56209-56218. PubMed ID: 27486823
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA MALAT1 activates autophagy and promotes cell proliferation by downregulating microRNA-204 expression in gastric cancer.
Shao G; Zhao Z; Zhao W; Hu G; Zhang L; Li W; Xing C; Zhang X
Oncol Lett; 2020 Jan; 19(1):805-812. PubMed ID: 31897197
[TBL] [Abstract][Full Text] [Related]
17. The Role of Genetic Variants in the Long Non-Coding RNA Genes
Shkurat TP; Ammar M; Bocharova O; Teplyakova E; Aleksandrova A; Ali R; Lipovich L
Noncoding RNA; 2023 Mar; 9(2):. PubMed ID: 37104004
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNAs H19, MALAT1 and MIAT as potential novel biomarkers for diagnosis of acute myocardial infarction.
Wang XM; Li XM; Song N; Zhai H; Gao XM; Yang YN
Biomed Pharmacother; 2019 Oct; 118():109208. PubMed ID: 31302423
[TBL] [Abstract][Full Text] [Related]
19. A genetic variant in long non-coding RNA MALAT1 associated with survival outcome among patients with advanced lung adenocarcinoma: a survival cohort analysis.
Wang JZ; Xiang JJ; Wu LG; Bai YS; Chen ZW; Yin XQ; Wang Q; Guo WH; Peng Y; Guo H; Xu P
BMC Cancer; 2017 Mar; 17(1):167. PubMed ID: 28253859
[TBL] [Abstract][Full Text] [Related]
20. High expression of long non-coding RNA MALAT1 in breast cancer is associated with poor relapse-free survival.
Wang Z; Katsaros D; Biglia N; Shen Y; Fu Y; Loo LWM; Jia W; Obata Y; Yu H
Breast Cancer Res Treat; 2018 Sep; 171(2):261-271. PubMed ID: 29845475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
